Centrus Energy Reports Tomorrow With HALEU Production Still More Promise Than Revenue

Centrus Energy Corp. (LEU) is set to report first-quarter 2026 earnings on May 5, 2026, after market close, with analysts expecting $0.50 per share on revenue of approximately $81.5 million. The central question: can the nuclear fuel supplier stabilize earnings after a sharp miss last quarter, or will execution challenges in its domestic HALEU enrichment facility and geopolitical supply chain risks continue to weigh on results? With the stock down roughly 15% year-to-date and trading well below its 100-day and 200-day moving averages, this report will test whether LEU can regain investor confidence in a volatile uranium market.

Part 1: Earnings Preview

Centrus Energy Corp. supplies enriched uranium fuel and related technical services to commercial nuclear power plants, with operations spanning its LEU segment (low-enriched uranium supply) and Technical Solutions segment (engineering and manufacturing services). The company is also developing domestic production capacity for High-Assay Low-Enriched Uranium (HALEU), a critical fuel for next-generation reactors, positioning itself at the intersection of energy security and advanced nuclear technology.

For the first quarter of 2026, analysts expect Centrus to report earnings of $0.50 per share, a sharp decline from the $0.91 per share the company reported in Q1 2025. The consensus estimate reflects a -45.05% year-over-year decline, underscoring concerns about near-term profitability as the company navigates a challenging operating environment. Revenue is projected at approximately $81.5 million, down roughly 11% from the prior-year quarter's $73.1 million, signaling weak top-line momentum.

Three key themes define this earnings story:

1. HALEU Production Ramp and Execution Risk: Centrus has produced over 920 kg of HALEU at its Ohio facility as of mid-2025, but scaling production to meet growing demand from advanced reactor developers remains a critical execution challenge. Investors will scrutinize updates on production capacity, customer contracts, and any delays that could undermine the company's first-mover advantage in this emerging market.

2. Geopolitical Supply Chain Dependence: Centrus relies heavily on its Russian TENEX contract for uranium enrichment services, a vulnerability that has drawn increasing scrutiny amid U.S.-Russia tensions and efforts to establish domestic fuel supply chains. Any disruption to this arrangement—or progress toward reducing reliance on Russian supply—will be closely watched, particularly as the U.S. government pushes for energy independence.

3. Uranium Market Volatility and Pricing Pressure: The broader uranium market experienced significant volatility in Q1 2026, with spot prices swinging between $80 and $150 per pound amid geopolitical shocks and uncertain utility contracting behavior. This volatility creates both opportunity and risk for Centrus, as pricing dynamics and inventory management directly impact margins and revenue visibility.

Ahead of the release, analysts have turned more cautious. Northland Securities recently cut its Q1 2026 EPS estimate to $0.94 from $1.40, citing weaker-than-expected near-term profitability. UBS lowered its price target from $245 to $195, while Citigroup reduced its target from $292 to $225. Zacks downgraded the stock to "hold," reflecting concerns about valuation and execution risk. However, the company's $3.9 billion order backlog—including $3.0 billion in the LEU segment—provides a cushion of contracted revenue, and bullish analysts point to Centrus's strategic positioning in the HALEU market as a long-term growth driver despite near-term headwinds.

Part 2: Historical Earnings Performance

Centrus Energy has delivered a mixed earnings track record over the past four quarters, with two significant beats followed by two disappointing results. In Q1 2025, the company reported $0.91 per share against an estimate of -$0.10, a stunning 1,010% surprise that reflected stronger-than-expected profitability. The momentum continued in Q2 2025, when LEU posted $1.59 per share versus a consensus of $0.78, beating by 103.85%. These back-to-back blowout quarters demonstrated the company's ability to capitalize on favorable uranium market conditions and operational leverage.

However, the trend reversed sharply in the second half of 2025. In Q3, Centrus reported $0.19 per share, narrowly missing the $0.20 estimate by 5%—a relatively minor shortfall but a clear deceleration from prior quarters. The real disappointment came in Q4 2025, when the company delivered $0.79 per share against expectations of $1.42, a -44.37% miss that sent the stock tumbling. This marked the largest earnings shortfall in the recent dataset and raised red flags about execution challenges, margin pressure, or timing issues in revenue recognition.

The pattern suggests Centrus is highly sensitive to quarterly fluctuations in contract timing, uranium pricing, and operational performance at its HALEU facility. The company's ability to consistently meet or beat estimates appears to have weakened in recent quarters, and the sharp Q4 miss has reset investor expectations lower heading into Q1 2026. With analysts now forecasting $0.50 per share—down 45% year-over-year—the bar has been lowered, but the question remains whether Centrus can stabilize earnings or if further downside surprises lie ahead.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Centrus Energy typically reports earnings after market close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full reaction to the actual numbers.

Centrus Energy exhibits extreme post-earnings volatility, with an average absolute Day +1 move of 16.68% and an average Day +1 range of 16.82%—far exceeding typical market behavior and reflecting the stock's sensitivity to quarterly results and guidance. The most recent earnings release on February 10, 2026, exemplifies this pattern: the stock dropped -20.69% on Day +1 following the Q4 2025 miss, with an intraday range of 19.54%. Similarly, the November 2025 report triggered a -14.72% decline despite a relatively minor earnings miss, underscoring how quickly sentiment can shift.

Positive surprises have historically driven sharp rallies. The May 2025 report—when LEU beat estimates by over 1,000%—sent the stock up +22.01% on Day +1, while the February 2025 blowout quarter produced a +33.13% surge. Even the August 2025 beat, though more modest, delivered a +8.70% gain. However, the Day 0 moves are far more muted (averaging just 3.18%), suggesting most of the price action occurs after investors digest the full earnings details and management commentary.

Investors should brace for significant volatility following the May 5 release. Given the stock's history of double-digit swings and the current uncertainty around HALEU production, supply chain risks, and uranium market dynamics, a move of 15–20% in either direction would not be unusual. The direction will hinge on whether Centrus can stabilize earnings, provide credible guidance, and demonstrate progress on its strategic initiatives—or if execution concerns and margin pressure trigger another sharp selloff.

Part 2.2: Options Market Expected Move

The options market is pricing in an expected move of 13.36% (±$27.65) through the May 15 expiration, which is notably lower than the stock's average historical Day +1 move of 16.68%. This suggests options traders may be underestimating the potential for post-earnings volatility, particularly given LEU's recent pattern of 15–20% swings following disappointing results. Investors using options to hedge or speculate should be aware that actual price movement could exceed the implied range, especially if the company delivers another significant earnings surprise in either direction.

Part 3: What Analysts Are Saying

Analysts maintain a cautiously optimistic stance on Centrus Energy, with a consensus rating of 4.00 (Buy) and an average price target of $269.46—implying 30% upside from the current price of $206.92. However, sentiment has deteriorated over the past month, as the average recommendation slipped from 4.13 and several firms downgraded their outlook following the disappointing Q4 2025 results.

The current breakdown shows 8 Strong Buys, 1 Moderate Buy, 5 Holds, and 1 Strong Sell among the 15 analysts covering the stock. Notably, one analyst shifted from Hold to Strong Sell in the past month, reflecting growing concerns about near-term execution risk and valuation. The price target range is wide, spanning from a low of $137 to a high of $390, underscoring the divergence in views on LEU's prospects. Bulls point to the company's strategic positioning in the HALEU market, its $3.9 billion order backlog, and long-term tailwinds from nuclear energy's resurgence as reasons for optimism. Bears, however, cite the company's dependence on Russian supply chains, execution challenges in scaling domestic production, and elevated valuation multiples (P/E of 47x, P/S of 8.1x) as reasons for caution.

The deterioration in sentiment is evident in recent analyst actions. Northland Securities slashed its 2026 and 2027 EPS estimates, while UBS and Citigroup reduced price targets by 20–23%. Zacks' downgrade to "hold" reflects a more neutral stance after the stock's sharp run-up in 2025 and subsequent pullback. Despite the recent downgrades, the consensus still leans bullish, with 60% of analysts rating the stock a Buy or Strong Buy. However, the widening gap between the high and low price targets—and the emergence of a Strong Sell rating—suggests investors should expect continued debate over LEU's valuation and near-term trajectory as the company navigates a volatile operating environment.

Part 4: Technical Picture

Centrus Energy enters earnings with a deteriorating technical picture, as the Barchart Technical Opinion has weakened from 100% Sell a month ago to 56% Sell last week, and now sits at 40% Sell. While the signal has moderated slightly in recent days, the overall trend remains negative, reflecting persistent selling pressure and a lack of sustained bullish momentum.

Timeframe Analysis:

• Short-term (Hold): Neutral signal suggests the stock is consolidating near current levels with no clear directional bias in the immediate term
• Medium-term (50% Sell): Moderate sell signal indicates weakness in the intermediate timeframe, with downside pressure still present
• Long-term (100% Sell): Strong sell signal reflects a firmly negative longer-term trend, with the stock trading well below key moving averages

Trend Characteristics: The combination of Weak strength and Weakest direction signals a fragile technical environment heading into earnings, with limited momentum and a bias toward further downside if results disappoint.

The stock is currently trading at $206.92, positioned above its 5-day ($204.42), 20-day ($199.85), and 50-day ($198.40) moving averages, suggesting some short-term stabilization after recent weakness. However, LEU remains below its 10-day ($207.79), 100-day ($232.60), and 200-day ($251.94) moving averages, indicating the longer-term trend is still broken. The 100-day and 200-day averages, in particular, represent significant overhead resistance, and the stock's failure to reclaim these levels underscores the bearish technical backdrop.

Key support lies near the 50-day moving average at $198.40, with a break below that level likely triggering further selling toward the $180–$190 range. On the upside, the 10-day moving average at $207.79 and the 100-day at $232.60 represent immediate resistance zones. The overall technical setup is cautionary heading into earnings: while the stock has stabilized in recent sessions, the longer-term trend remains negative, and the weak momentum environment suggests limited cushion for disappointment. A strong earnings beat and credible guidance could spark a rally back toward the 100-day moving average, but another miss risks accelerating the downtrend and testing the $180 support zone. Investors should be prepared for heightened volatility and consider the technical fragility when positioning for the May 5 release.